Outlook Therapeutics, Inc. (OTLK): SC 13D/A filed Mar 20, 2024

Form type

SC 13D/A

Filing date

Mar 20, 2024

Accession number

0000947871-24-000292

Filer

Outlook Therapeutics, Inc. (CIK 1649989)